J. C. Mani

529 total citations
18 papers, 441 citations indexed

About

J. C. Mani is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. C. Mani has authored 18 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. C. Mani's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Enzyme function and inhibition (2 papers). J. C. Mani is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Enzyme function and inhibition (2 papers). J. C. Mani collaborates with scholars based in France, Switzerland and United Kingdom. J. C. Mani's co-authors include Jacques Dornand, J.C. Bonnafous, Cécile Calleja, Jean‐Marc Pascussi, P Maurel, M.J. Vilarem, J.-P. Mach, J. P. CHAPAT, Pierre‐Antoine Bonnet and A.D. Michel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J. C. Mani

18 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. C. Mani France	11	198	108	95	69	62	18	441
Wijnholt Ferwerda Netherlands	13	370 1.9×	80 0.7×	80 0.8×	70 1.0×	35 0.6×	24	485
Cathy A. Farrell United States	11	375 1.9×	167 1.5×	50 0.5×	64 0.9×	108 1.7×	14	718
William A. Stylos United States	13	158 0.8×	164 1.5×	87 0.9×	39 0.6×	104 1.7×	32	547
Parker Cw Australia	9	157 0.8×	79 0.7×	35 0.4×	27 0.4×	50 0.8×	23	424
Mark E. Lesch United States	12	200 1.0×	124 1.1×	63 0.7×	81 1.2×	64 1.0×	17	544
S Fujimoto Japan	13	166 0.8×	151 1.4×	45 0.5×	44 0.6×	93 1.5×	41	455
Mark Hilliard Ireland	13	475 2.4×	210 1.9×	137 1.4×	96 1.4×	53 0.9×	15	794
Richard B. Whitney Canada	12	269 1.4×	306 2.8×	41 0.4×	38 0.6×	130 2.1×	20	668
Matthias Blumrich Germany	9	239 1.2×	114 1.1×	61 0.6×	38 0.6×	145 2.3×	12	496
Melvin L. Goldberg United States	13	178 0.9×	123 1.1×	17 0.2×	24 0.3×	30 0.5×	22	370

Countries citing papers authored by J. C. Mani

Since Specialization

Citations

This map shows the geographic impact of J. C. Mani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Mani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Mani more than expected).

Fields of papers citing papers by J. C. Mani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Mani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Mani. The network helps show where J. C. Mani may publish in the future.

Co-authorship network of co-authors of J. C. Mani

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Mani. A scholar is included among the top collaborators of J. C. Mani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Mani. J. C. Mani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Couty, S., Alexey V. Terskikh, Martine Pugnière, et al.. (2000). Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Molecular Immunology. 37(17). 1067–1077. 67 indexed citations

Gaillard, J, J. C. Mani, Jean‐Pierre Liautard, Barbara K. Klein, & J Brochier. (1999). Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.. PubMed. 10(1). 43–8. 9 indexed citations

Calleja, Cécile, Jean‐Marc Pascussi, J. C. Mani, P Maurel, & M.J. Vilarem. (1998). The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nature Medicine. 4(1). 92–96. 85 indexed citations

Calleja, Cécile, Jean‐Marc Pascussi, J. C. Mani, P Maurel, & M.J. Vilarem. (1998). Reply to Rifampicin: a glucocorticoid receptor ligand?. Nature Medicine. 4(10). 1090–1091. 4 indexed citations

Gaillard, J, Jean‐Pierre Liautard, J. C. Mani, et al.. (1996). Identification of a novel antigenic structure of the human receptor for interleukin‐6 involved in the interaction with the glycoprotein 130 chain. Immunology. 89(1). 135–141. 8 indexed citations

Robert, Bruno, J.-P. Mach, J. C. Mani, et al.. (1996). Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.. PubMed. 56(20). 4758–65. 32 indexed citations

Cohen, Pascale A., Anne‐Paule Gimenez‐Roqueplo, J. C. Mani, et al.. (1996). Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis.. The Journal of Clinical Endocrinology & Metabolism. 81(10). 3505–3512. 11 indexed citations

Barrowcliffe, Trevor W., et al.. (1994). Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.. Journal of Biological Chemistry. 269(47). 29435–29443. 25 indexed citations

Bonnet, Pierre‐Antoine, et al.. (1992). Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazines. Journal of Medicinal Chemistry. 35(18). 3353–3358. 61 indexed citations

10.

Piechaczyk, Martine, J M Scherrmann, Jill M. Grenier, et al.. (1991). Highly Specific Radioimmunoassay for Digoxin Using a Monoclonal Antibody Selected for Lack of Interference by Digoxin-Like Immunoreactive Substances in Cord Blood Sera. Therapeutic Drug Monitoring. 13(2). 113–119. 9 indexed citations

11.

Dornand, Jacques & J. C. Mani. (1988). Lymphocyte Activation and Differentiation. 39 indexed citations

12.

Dornand, Jacques, et al.. (1987). Amiloride-induced suppression of lymphocyte proliferation: Inhibition of IL 2 receptor expression after blockade of early sodium influx. Immunobiology. 174(4-5). 365–379. 4 indexed citations

13.

Dornand, Jacques, et al.. (1986). Mechanism whereby Ouabain Inhibits Human T Lymphocyte Activation: Effect on the Interleukin 2 Pathway. Immunobiology. 171(4-5). 436–450. 27 indexed citations

14.

Dornand, Jacques, et al.. (1985). Purine Metabolizing Enzymes of Lymphocyte Cell Populations: Correlation between AMP-Deaminase Activity and dATP Accumulation in Murine Lymphocytes. Experimental Biology and Medicine. 179(4). 448–455. 1 indexed citations

15.

Bonnafous, J.C., et al.. (1984). Characterization of peanut agglutinin receptors of murine thymocytes. Cellular Immunology. 86(2). 439–447. 15 indexed citations

16.

Dornand, Jacques, et al.. (1984). Paradoxical production of mouse thymocyte activating factor by ouabain-treated human mononuclear cells. Cellular Immunology. 83(2). 351–359. 12 indexed citations

17.

Bonnafous, J.C., et al.. (1981). Lymphocyte Membrane Adenosine Receptors Coupled to Adenylate Cyclase Properties and Occurrence in Various Lymphocyte Subclasses. Journal of Receptor Research. 2(4). 347–366. 29 indexed citations

18.

Mani, J. C., et al.. (1973). Etude par fluorescence de la complexation du TNS avec la 17 β-Hydroxysteroïde deshydrogenase placentaire. Biochimie. 55(8). 851–857. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact